E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more

The All In podcast episode features David Sacks, David Friedberg, and Chamath Palihapitiya discussing a range of topics, starting with the FDA's approval of Biogen's Alzheimer's drug and the ethical and economic implications. They then transition to Jeff Bezos's upcoming space flight and the broader space race, debating the role of government funding and potential military applications. The conversation shifts to work-from-home policies at major tech companies like Apple and Facebook, touching on supervision challenges and the impact on commercial real estate. They analyze the housing crisis, the influence of hedge funds, and potential solutions like modular homes and regulatory changes. The hosts also discuss the ProPublica leak of tax records, wealth inequality, and potential tax reforms. Finally, they delve into the Bitcoin conference in Miami, Bitcoin toxicity, and the broader cultural and economic anxieties driving interest in cryptocurrencies, ending with a discussion on the importance of meritocracy, innovation, and competition with China.